Ravindra Kumar, SVP & Chief Scientific Officer at ACCELERON PHARMA INC (XLRN), sold 2,000 shares at $27.60 ($55K) on 2017-01-04, disclosed to the SEC on 2017-01-06.
Scheduled sale ($55k) by SVP & Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.81 | 359 | $10K | 17.5% |
| 2 | $27.60 | 1,641 | $45K | 82.5% |
| Total | $27.46 avg | 2,000 | $55K | 100% |
| Filing → |
| XLRN | SELL | 2019-01-04 | $249K | — | Filing → |
| XLRN | SELL | 2018-04-04 | $46K | — | Filing → |
| XLRN | SELL | 2018-01-04 | $182K | — | Filing → |